Surmodics, Inc. announced results from a sex-specific analysis of its ongoing PROWL registry evaluating real-world use of the ...

InterVene, Inc. recently announced that it has received 510(k) clearance from the FDA for its Recana thrombectomy catheter ...

BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

Johnson & Johnson MedTech announced 1-year results from the DISRUPT BTK II postmarket study, demonstrating sustained safety ...

Amplitude Vascular Systems (AVS) announced results from the first 95 patients treated in the POWER PAD II United States ...

Contego Medical announced 30-day outcomes from the PERFORMANCE III study evaluating the Neuroguard IEP system for direct transc ...

Merit Medical Systems, Inc. announced 24-month efficacy outcomes from the nonrandomized arteriovenous graft (AVG) cohort of the ...

Penumbra, Inc. announced that results of the STORM-PE randomized controlled trial (RCT) were presented at VIVA 2025, the Vascul ...

InspireMD, Inc. announced the appointment of Peter A. Soukas, MD, as Chief Medical Officer. InspireMD is the developer of the C ...

Endovascular Engineering, Inc. (E2) announced positive results from the pivotal cohort of the ENGULF investigational device exe ...

Egg Medical, Inc. announced the presentation of real-world studies demonstrating that the company’s EggNest Complete radi ...

HistoSonics, Inc., developer of the Edison histotripsy system and histotripsy therapy platform, announced the closing of $250 m ...